Related Experiment Video
Updated: Aug 13, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Hepatitis C Care Cascade Analysis: Assessing the Gaps in the Pathway from Screening to Treatment]
Hatun Öztürk Çerik1, Arzu Altunçekiç Yildirim1, Celali Kurt1
1Ordu University Faculty of Medicine Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Ordu, Türkiye.
Insights
Gaps in hepatitis C virus (HCV) diagnosis and treatment prevent elimination. This study found significant patient loss to follow-up in Ordu province, highlighting the need for improved linkage-to-care strategies to meet elimination goals.
Area of Science:
- Hepatology and Viral Gastroenterology
- Public Health and Epidemiology
- Health Services Research
Abstract:
Although hepatitis C virus (HCV) infection is a curable disease with effective treatments today, gaps in the diagnostic and treatment steps remain the biggest obstacle to elimination. This study aimed to analyze the care cascade of the patients detected as positive for anti-HCV, determine linkage-to-care rates for confirmatory testing (HCV-RNA) and treatment and evaluate the attainability of microelimination targets at the provincial level.This retrospective, cross-sectional study included individuals tested for anti-HCV across all healthcare institutions in Ordu province between January 1, 2021 and December 31, 2024. Data were obtained from the Provincial Directorate of Health and a tertiary referral center and cross-analyzed. Rates of confirmatory HCV-RNA testing, viremia, treatment initiation and lost to follow-up at each step of the cascade of care were evaluated. Over the four-year period, 225.218 individuals were screened (29.2% of the provincial population) and anti-HCV seroprevalence was found to be 0.55% (n= 1241). The majority of test requests were made by surgical departments (38%) and family medicine units (26%). It was determined that only 47.5% (n= 590) of anti-HCV positive patients underwent HCV-RNA confirmatory testing; the remaining 52.5% (n= 651) were lost to follow-up in the diagnostic process. Viremia was detected in 17.2% (n=102) of the patients who underwent HCV-RNA testing. It was found that 69.6% (n= 71) of viremic patients initiated treatment, while 15.7% (n= 16) could not access treatment despite receiving a diagnosis. This study presented a comprehensive, population-based province-level HCV care cascade for the first time in Türkiye. The results demonstrate that insufficient linkage-to-care, resulting in substantial loss to follow-up during diagnostic and treatment stages, represents the primary barrier to HCV elimination. To achieve World Health Organization 2030 goals, micro-elimination strategies such as reflex testing implementation, automated alerts integrated into hospital information systems and active recall of patients lost to follow-up must be implemented.
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Hepatitis
Traditional Level Of Health Care System
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
